title: Landmark lupus approval opens door for next wave of drugs.
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic / Q000379:methods; D017277:Drug Approval; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods; D023281:Genomics / Q000379:methods; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C511911:belimumab